ScreenerHero

ALECR Eurofins-Cerep SA

EPA · FR · Healthcare · Diagnostics & Research · eurofins.fr
18100.00EUR0.00%Mkt Cap: 99.24M $P/E: 11.75

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound man…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap99.24M USD
Enterprise Value—
Revenue (TTM)44.67M USD
Gross Profit23.83M USD
Net Income (TTM)5.20M USD
Revenue/Share—
Last Price18100.00 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)11.75
P/E (Forward)—
PEG3.26
EV/EBITDA—
EV/Revenue—
P/S2.22
P/B—
EPS (TTM)1540.15
EPS (Forward)—
52W Range
15000.0086% of range18600.00
52W High18600.00 EUR
52W Low15000.00 EUR
Profitability
Gross Margin53.49%
Oper. Margin10.17%
EBITDA Margin13.94%
Profit Margin11.67%
ROE6.25%
ROA5.37%
Growth
Revenue Growth10.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-22.86M USD
Net Debt/EBITDA-3.67
Balance Sheet
Debt/Equity0.00
Current Ratio7.83
Quick Ratio7.53
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateJul 27, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.04K
Float—
Insiders95.78%
Institutions0.00%
Technical
SMA 5017186.00 (+5.3%)
SMA 20016636.00 (+8.8%)
Beta0.02
S&P 52W Chg14.58%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)56.8
MACD231.8960
MACD Signal213.1199
MACD Hist.+18.7761
BB Upper19759.46 EUR
BB Middle17845.00 EUR
BB Lower15930.54 EUR
BB Width21.46%
ATR (14)276.66 EUR
Vol Ratio (20d)0.00x